Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges

Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges

The management of human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer (BC) has changed in recent years thanks to the introduction of anti-HER2 agents in clinical practice as standard of care in the neoadjuvant setting. In this scenario, we probed the issue of which HER...

Full description

Bibliographic Details
Main Authors: Luigia Stefania Stucci, Marco Pisino, Claudia D’Addario, Teresa Grassi, Angela Toss
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
HER2+ breast cancer
early stage
treatment
Italy management
clinical practice
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.871160/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.871160/full

Similar Items